Alligator Bioscience AB (OSTO:ATORX)
kr 0.032 -0.0026 (-7.51%) Market Cap: 20.10 Mil Enterprise Value: 19.50 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 0/100

Q2 2026 Alligator Bioscience AB Earnings Call Transcript

Aug 26, 2026 / 01:00PM GMT
Release Date Price: kr0.0346 (+22.26%)
Greta Hoog
Alligator Bioscience AB - Investor Relations and Communications Manager

Welcome to Alligator Biosciences interim report call for the Second Quarter of 2026. My name is Greta Hoog. I am the IR and Communications Manager at Alligator and I will be introducing today's call. With me today is our CEO, Soren Bregenholt, and our CFO, Johan Gileus. They will walk you through the latest developments at the company, after which they will be happy to answer any questions you may have.

You may either submit these questions in the Q&A function of this chat or you may e-mail them to IR at alligatorbioscience.com.

As you know, Alligator Bioscience as a publicly listed company. And I would like to note that today's presentation may include forward-looking statements. Please refer to the disclaimer on this side and to the next slide for the whole presentation.

And with this, I would like to turn the call over to you, Soren.

Soren Bregenholt
Alligator Bioscience AB - Chief Executive Officer

Thank you, Greta. And once again, welcome

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot